Glencar to design and build new 70,000 sq. ft multi-occupier, tech development.
26th March 2025
This project represents a significant milestone in Glencar’s expansion into the commercial sector.
Harwell appoints Glencar to design and build new 70,000 sq. ft multi-occupier, tech development.
The project situated at Harwell Science and Innovation Campus, will see the construction of multiple units in a base design for shell ready for future tenant fit-out.
Glencar has announced its appointment as the main contractor Harwell Science and Innovation Campus for the design and build of a new 70,000 sq. ft multi-occupier, tech development being developed speculatively at the campus.
The project will involve constructing a state-of-the-art, multi-use building, designed to provide flexible leasing options for multiple mid-tech units. The development will be delivered to a ‘shell’ specification, allowing future tenants the flexibility to customise the space to meet their specific requirements.
Construction began in March, with an initial six-week enabling works phase, and the overall development is scheduled for completion in February 2026, with a total build programme of 50 weeks.
Key Features and Sustainability Commitments
- Extensive cut & fill works, ground stabilisation, and retaining wall installations
- Pad foundations, steel frame with recycled content, and standing seam roofing & cladding
- Curtain walling and high-quality hard & soft landscaping
- Designed to meet Carbon Net Zero in construction
- Targeting BREEAM Very Good certification for sustainability excellence
- High-specification envelope design with superior finishes and attention to detail
A Strong Partnership and Commitment to Innovation
This project marks Glencar’s third life sciences development for Harwell, following the recent successful completion of a pharmaceutical and biotech manufacturing facility at Harwell Science and Innovation Campus.
In addition to Harwell, Glencar is currently delivering a 60,000 sq. ft fully fitted laboratory and office building at Chesterford Research Park in Cambridge for Aviva Investors, further solidifying its credentials in the life sciences sector.
As demand for specialist laboratory and research space continues to grow, Glencar is playing a key role in shaping the future of life sciences infrastructure, contributing to the UK’s ambition to lead in scientific research and innovation.
Jason Stafford
Harwell


